Drug Product
Company Overview
About
Senores Group is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Neurology
Quick Facts
HQ:India
Founded:2012
Employees:708
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
Europe
Regulatory Approvals
Drug Approval WJ7B3R
Health Canada · #APR-HE7W1691 · 2018-05-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-HQNRL9LW
Issued: 2020-03-11
Expires: 2025-11-25
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-YK85A0KT
Issued: 2020-12-28
Expires: 2025-03-15
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-2CT606AL
Issued: 2020-11-03
Expires: 2025-07-06
Loading CDMO intelligence...
Key facts about Senores Group
- Senores Group is headquartered in India.
- Senores Group was founded in 2012.
- Senores Group has 708 employees.
- Senores Group's capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Senores Group
Directory pages this company appears in, each with the full list of matching manufacturers.